Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine

BACKGROUND: The existence of SARS-CoV-2 variants of concern (VOCs) in association with evidence of breakthrough infections despite vaccination resulted in the need for vaccine boosting. In elderly individuals, information on the immunogenicity of booster vaccinations is limited. In countries where t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liwsrisakun, Chalerm, Pata, Supansa, Laopajon, Witida, Takheaw, Nuchjira, Chaiwong, Warawut, Inchai, Juthamas, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Chuensirikulchai, Kantinan, Kasinrerk, Watchara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126751/
https://www.ncbi.nlm.nih.gov/pubmed/35610643
http://dx.doi.org/10.1186/s12979-022-00279-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126751/
https://www.ncbi.nlm.nih.gov/pubmed/35610643
http://dx.doi.org/10.1186/s12979-022-00279-8

Ejemplares similares